Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Pileri

Showing results (141-150 of 165) with videos related to

Pageof 17
Sort By:
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 7, 2022
Management of malignant cutaneous wounds in oncologic patientsMichela Starace, Miriam Anna Carpanese, Francesca Pampaloni, et al.
Experimental Hematology|June 14, 2002
Real-time polymerase chain reaction in multiple myeloma: quantitative analysis of tumor contamination of stem cell harvestsMarco Ladetto, Paola Omedè, Selina Sametti, et al.
Sexually Transmitted Infections|January 29, 2025
Scabies increasing incidence in Bologna from 2013 to 2024: a retrospective analysisCorrado Zengarini, Martina Mussi, Michelangelo La Placa, et al.
British Journal of Haematology|September 14, 2025
Quality and duration of responses with mogamulizumab in cutaneous T-cell lymphomas: Insights into long-lasting outcomesAlessandro Broccoli, Lisa Argnani, Alessandro Pileri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 21, 2008
Rituximab improves the efficacy of high-dose chemotherapy with autograft for high-risk follicular and diffuse large B-cell lymphoma: a multicenter Gruppo Italiano Terapie Innnovative nei linfomi surveyCorrado Tarella, Manuela Zanni, Michele Magni, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 4, 2025
Mogamulizumab-induced alopecia. Multicentric case series: Clinical, trichoscopic and histological characterizationRaquel Cavestany Rodríguez, Daniel Falkenhain López, Pablo L Ortiz-Romero, et al.
Blood|January 5, 2002
Reduced-intensity conditioning followed by allografting of hematopoietic cells can produce clinical and molecular remissions in patients with poor-risk hematologic malignanciesPaolo Corradini, Corrado Tarella, Attilio Olivieri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2003
PCR-detectable nonneoplastic Bcl-2/IgH rearrangements are common in normal subjects and cancer patients at diagnosis but rare in subjects treated with chemotherapyMarco Ladetto, Daniela Drandi, Mara Compagno, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2006
Prognostic factors in primary cutaneous B-cell lymphoma: the Italian Study Group for Cutaneous LymphomasPier Luigi Zinzani, Pietro Quaglino, Nicola Pimpinelli, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 5, 2022
Real-world data on primary cutaneous lymphoproliferative disorders following SARS-CoV-2 vaccination: A multicentre experience from tertiary referral hospitalsGianluca Avallone, Carlo Alberto Maronese, Claudio Conforti, et al.
Pageof 17

Showing results (141-150 of 165) with videos related to

Sort By:
Pageof 17
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 7, 2022
Management of malignant cutaneous wounds in oncologic patientsMichela Starace, Miriam Anna Carpanese, Francesca Pampaloni, et al.
Experimental Hematology|June 14, 2002
Real-time polymerase chain reaction in multiple myeloma: quantitative analysis of tumor contamination of stem cell harvestsMarco Ladetto, Paola Omedè, Selina Sametti, et al.
Sexually Transmitted Infections|January 29, 2025
Scabies increasing incidence in Bologna from 2013 to 2024: a retrospective analysisCorrado Zengarini, Martina Mussi, Michelangelo La Placa, et al.
British Journal of Haematology|September 14, 2025
Quality and duration of responses with mogamulizumab in cutaneous T-cell lymphomas: Insights into long-lasting outcomesAlessandro Broccoli, Lisa Argnani, Alessandro Pileri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 21, 2008
Rituximab improves the efficacy of high-dose chemotherapy with autograft for high-risk follicular and diffuse large B-cell lymphoma: a multicenter Gruppo Italiano Terapie Innnovative nei linfomi surveyCorrado Tarella, Manuela Zanni, Michele Magni, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 4, 2025
Mogamulizumab-induced alopecia. Multicentric case series: Clinical, trichoscopic and histological characterizationRaquel Cavestany Rodríguez, Daniel Falkenhain López, Pablo L Ortiz-Romero, et al.
Blood|January 5, 2002
Reduced-intensity conditioning followed by allografting of hematopoietic cells can produce clinical and molecular remissions in patients with poor-risk hematologic malignanciesPaolo Corradini, Corrado Tarella, Attilio Olivieri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2003
PCR-detectable nonneoplastic Bcl-2/IgH rearrangements are common in normal subjects and cancer patients at diagnosis but rare in subjects treated with chemotherapyMarco Ladetto, Daniela Drandi, Mara Compagno, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2006
Prognostic factors in primary cutaneous B-cell lymphoma: the Italian Study Group for Cutaneous LymphomasPier Luigi Zinzani, Pietro Quaglino, Nicola Pimpinelli, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 5, 2022
Real-world data on primary cutaneous lymphoproliferative disorders following SARS-CoV-2 vaccination: A multicentre experience from tertiary referral hospitalsGianluca Avallone, Carlo Alberto Maronese, Claudio Conforti, et al.
Pageof 17